Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Jurcic, Joseph Gerard
70  Ergebnisse:
Personensuche X
?
1

Targeted Radionuclide Therapy:

, In: Clinical Radiation Oncology,
Jurcic, Joseph Gerard ; Wong, Jeffrey Y.C. ; Knox, Susan J.... - p. 399-418.e14 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Contributors:

, In: Clinical Radiation Oncology,
Abrams, Ross A. ; Adelstein, David J. ; Alektiar, Kaled M.... - p. vii-xv , 2016
Link: https://doi.org/10.1016/..
 
?
3

Olutasidenib (FT-2102) induces durable complete remissions ..:

de Botton, Stéphane ; Fenaux, Pierre ; Yee, Karen...
Blood Advances.  7 (2023)  13 - p. 3117-3127 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Targeting RARA overexpression with tamibarotene, a potent a..:

de Botton, Stéphane ; Cluzeau, Thomas ; Vigil, Carlos...
Blood Advances.  7 (2023)  9 - p. 1858-1870 , 2023
Link: https://doi.org/10.1182/..
 
?
5

Luspatercept for myelodysplastic syndromes/myeloproliferati..:

Komrokji, Rami S. ; Platzbecker, Uwe ; Fenaux, Pierre...
Leukemia.  36 (2022)  5 - p. 1432-1435 , 2022
Link: https://doi.org/10.1038/..
 
?
6

Longer-term benefit of luspatercept in transfusion-dependen..:

Zeidan, Amer M. ; Platzbecker, Uwe ; Garcia-Manero, Guillermo...
Blood.  140 (2022)  20 - p. 2170-2174 , 2022
Link: https://doi.org/10.1182/..
 
?
7

AML-256 A Phase 1 Study of Gilteritinib in Combination With..:

Pratz, Keith W. ; Cherry, Mohamad ; Podoltsev, Nikolai A....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S230 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Poster: AML-256 A Phase 1 Study of Gilteritinib in Combinat..:

Pratz, Keith W. ; Cherry, Mohamad ; Podoltsev, Nikolai A....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S126 , 2022
Link: https://doi.org/10.1016/..
 
?
9

A Phase I dose‐escalation study of DCLL9718S, an antibody‐d..:

Daver, Naval ; Salhotra, Amandeep ; Brandwein, Joseph M....
American Journal of Hematology.  96 (2021)  5 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
10

Rewriting the rules for care of MDS and AML patients in the..:

Raza, Azra ; Assal, Amer ; Ali, Abdullah M..
Leukemia Research Reports.  13 (2020)  - p. 100201 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Targeted Alpha-Particle Therapy for Hematologic Malignancie:

Jurcic, Joseph G.
Seminars in Nuclear Medicine.  50 (2020)  2 - p. 152-161 , 2020
Link: https://doi.org/10.1053/..
 
?
12

MDS-280: Longer-Term RBC Transfusion Reduction in the Phase..:

Komrokji, Rami S. ; Sekeres, Mikkael A. ; Zeidan, Amer M....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S322 , 2020
Link: https://doi.org/10.1016/..
 
?
13

MDS-179: Clinical Benefit of Luspatercept in Patients with ..:

Zeidan, Amer M. ; Garcia-Manero, Guillermo ; DeZern, Amy E....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S318-S319 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpe..:

Maslak, Peter G. ; Dao, Tao ; Bernal, Yvette...
Blood Advances.  2 (2018)  3 - p. 224-234 , 2018
Link: https://doi.org/10.1182/..
 
?
15

Trial in Progress: A Phase I/II Study of Lintuzumab-Ac225 i..:

Jurcic, Joseph G. ; Levy, Moshe ; Park, Jae...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  - p. S277 , 2017
Link: https://doi.org/10.1016/..
 
1-15